These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 17604275)
1. Elevation of cellular NAD levels by nicotinic acid and involvement of nicotinic acid phosphoribosyltransferase in human cells. Hara N; Yamada K; Shibata T; Osago H; Hashimoto T; Tsuchiya M J Biol Chem; 2007 Aug; 282(34):24574-82. PubMed ID: 17604275 [TBL] [Abstract][Full Text] [Related]
2. Characterization of human nicotinate phosphoribosyltransferase: Kinetic studies, structure prediction and functional analysis by site-directed mutagenesis. Galassi L; Di Stefano M; Brunetti L; Orsomando G; Amici A; Ruggieri S; Magni G Biochimie; 2012 Feb; 94(2):300-9. PubMed ID: 21742010 [TBL] [Abstract][Full Text] [Related]
3. FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. Hasmann M; Schemainda I Cancer Res; 2003 Nov; 63(21):7436-42. PubMed ID: 14612543 [TBL] [Abstract][Full Text] [Related]
4. A Versatile Continuous Fluorometric Enzymatic Assay for Targeting Nicotinate Phosphoribosyltransferase. Minazzato G; Marangoni E; Fortunato C; Petrelli R; Cappellacci L; Del Bello F; Sorci L; Gasparrini M; Piacente F; Bruzzone S; Raffaelli N Molecules; 2023 Jan; 28(3):. PubMed ID: 36770640 [TBL] [Abstract][Full Text] [Related]
5. Supplementation of nicotinic acid with NAMPT inhibitors results in loss of in vivo efficacy in NAPRT1-deficient tumor models. O'Brien T; Oeh J; Xiao Y; Liang X; Vanderbilt A; Qin A; Yang L; Lee LB; Ly J; Cosino E; LaCap JA; Ogasawara A; Williams S; Nannini M; Liederer BM; Jackson P; Dragovich PS; Sampath D Neoplasia; 2013 Dec; 15(12):1314-29. PubMed ID: 24403854 [TBL] [Abstract][Full Text] [Related]
6. Extensive regulation of nicotinate phosphoribosyltransferase (NAPRT) expression in human tissues and tumors. Duarte-Pereira S; Pereira-Castro I; Silva SS; Correia MG; Neto C; da Costa LT; Amorim A; Silva RM Oncotarget; 2016 Jan; 7(2):1973-83. PubMed ID: 26675378 [TBL] [Abstract][Full Text] [Related]
7. Selective Cytotoxicity of the NAMPT Inhibitor FK866 Toward Gastric Cancer Cells With Markers of the Epithelial-Mesenchymal Transition, Due to Loss of NAPRT. Lee J; Kim H; Lee JE; Shin SJ; Oh S; Kwon G; Kim H; Choi YY; White MA; Paik S; Cheong JH; Kim HS Gastroenterology; 2018 Sep; 155(3):799-814.e13. PubMed ID: 29775598 [TBL] [Abstract][Full Text] [Related]
8. Protection of nicotinic acid against oxidative stress-induced cell death in hepatocytes contributes to its beneficial effect on alcohol-induced liver injury in mice. Dou X; Shen C; Wang Z; Li S; Zhang X; Song Z J Nutr Biochem; 2013 Aug; 24(8):1520-8. PubMed ID: 23465591 [TBL] [Abstract][Full Text] [Related]
9. Nicotinic Acid Phosphoribosyltransferase Regulates Cancer Cell Metabolism, Susceptibility to NAMPT Inhibitors, and DNA Repair. Piacente F; Caffa I; Ravera S; Sociali G; Passalacqua M; Vellone VG; Becherini P; Reverberi D; Monacelli F; Ballestrero A; Odetti P; Cagnetta A; Cea M; Nahimana A; Duchosal M; Bruzzone S; Nencioni A Cancer Res; 2017 Jul; 77(14):3857-3869. PubMed ID: 28507103 [TBL] [Abstract][Full Text] [Related]
10. NAD Synthesis Pathway Interference Is a Viable Therapeutic Strategy for Chondrosarcoma. Peterse EFP; van den Akker BEWM; Niessen B; Oosting J; Suijker J; de Jong Y; Danen EHJ; Cleton-Jansen AM; Bovée JVMG Mol Cancer Res; 2017 Dec; 15(12):1714-1721. PubMed ID: 28860121 [TBL] [Abstract][Full Text] [Related]
11. Novel NAPRT specific antibody identifies small cell lung cancer and neuronal cancers as promising clinical indications for a NAMPT inhibitor/niacin co-administration strategy. Cole J; Guiot MC; Gravel M; Bernier C; Shore GC; Roulston A Oncotarget; 2017 Sep; 8(44):77846-77859. PubMed ID: 29100430 [TBL] [Abstract][Full Text] [Related]
12. NAPRT, but Not NAMPT, Provides Additional Support for NAD Synthesis in Esophageal Precancerous Lesions. Wang N; Pan D; Wang X; Su M; Wang X; Yan Q; Sun G; Wang S Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432602 [TBL] [Abstract][Full Text] [Related]
13. Identification of a nicotinamide/nicotinate mononucleotide adenylyltransferase in Forero-Baena N; Sánchez-Lancheros D; Buitrago JC; Bustos V; Ramírez-Hernández MH Biochim Open; 2015; 1():61-69. PubMed ID: 29632831 [No Abstract] [Full Text] [Related]
14. Expression patterns of nicotinamide phosphoribosyltransferase and nicotinic acid phosphoribosyltransferase in human malignant lymphomas. Olesen UH; Hastrup N; Sehested M APMIS; 2011 Apr; 119(4-5):296-303. PubMed ID: 21492230 [TBL] [Abstract][Full Text] [Related]
15. Enzyme activities leading to NAD synthesis in human lymphocytes. Sestini S; Jacomelli G; Pescaglini M; Micheli V; Pompucci G Arch Biochem Biophys; 2000 Jul; 379(2):277-82. PubMed ID: 10898945 [TBL] [Abstract][Full Text] [Related]
16. Identification of NAPRT Inhibitors with Anti-Cancer Properties by In Silico Drug Discovery. Ghanem MS; Caffa I; Del Rio A; Franco J; Parenti MD; Monacelli F; Cea M; Khalifa A; Nahimana A; Duchosal MA; Ravera S; Bertola N; Bruzzone S; Nencioni A; Piacente F Pharmaceuticals (Basel); 2022 Jul; 15(7):. PubMed ID: 35890147 [TBL] [Abstract][Full Text] [Related]